Skip to content

MRVI MARAVAI LIFESCIENCES HLDGS I

Follow

COMMON STOCK (common), issuer CIK 1823239

Filings received so far for Q3 2026: 2 13F filers report a position in MRVI shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Brust Bernddirector, officer (Chief Executive Officer)2026-10-08-29,250 F$7.43Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Farther Finance Advisors, LLC4,135$31.7K<0.01%+2213F-HRTimeline
GAMMA Investing LLC1,166$8.93K<0.01%+28213F-HRTimeline

Events

  • Brust Bernd disposed of 29,250 MRVI shares on 2026-10-08, Form 4 filed 2026-10-09. 0001380632-26-000010

    Accepted , ingested
  • MILLENNIUM MANAGEMENT LLC and 2 other reporting persons reported 7,773,149 MRVI shares, 5.2% of the class, as of 2026-09-22, in a 13G filed 2026-09-29. 0001104659-26-112023

    Accepted , ingested